How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...
A new frontier AI company called Recursive Superintelligence has emerged from stealth with $650 million in funding and an ...
Washington — President Trump on Thursday said he is nominating Dr. Nicole B. Saphier to be the next U.S. surgeon general, replacing his nomination of Casey Means, whose bid had stalled in the Senate ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Hosted on MSN
Recursion eyes breakthrough with REC-4881 drug for rare genetic condition, but shares pull back
Earlier this year, Recursion Pharmaceuticals Inc RXRX initiated discussions with the FDA for the design of a registrational study for its experimental drug REC-4881 in familial adenomatous polyposis ...
Credit: VentureBeat made with OpenAI ChatGPT-Images-2.0 Runpod, the high-performance cloud computing and GPU platform designed specifically for AI development, today launched a new open source, MIT ...
President Donald Trump on Thursday announced a new nominee for surgeon general, Dr. Nicole Saphier, putting an end to months of speculation about whether the Senate would confirm his prior pick, Dr.
The General Committee is composed of the President of the General Assembly and 21 Vice-Presidents of the Assembly and the Chairpersons of the six Main Committees. The five permanent members of the ...
Established in 1945 under the Charter of the United Nations, the General Assembly occupies a central position as the chief deliberative, policymaking and representative organ of the United Nations.
Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.30, demonstrating a -3.23% change from the preceding day's closing price. This change lagged the S&P 500's 0.04% loss on the day ...
Vikki Velasquez is a researcher and writer who has managed, coordinated, and directed various community and nonprofit organizations. She has conducted in-depth research on social and economic issues ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results